In conjunction with
Supported by
Scientific Partner
In collaboration with
About Event
Excellence in Oncology Care 2022
The landscape for Oncology Care is changing at a rapid pace. With EIOC we envision this platform be a meeting ground for global and regional experts to meet for better learnings and take away valuable experiences to their workplace. EIOC which stands for Excellence in Oncology Care is a platform for not just one cancer specialty but a holistic approach to 14 sub therapies within Oncology.
When
21 – 23 October, 2022
Where
Intercontinental Festical City, Dubai, United Arab Emirates
- 00Days
- 00Hours
- 00Minutes
- 00Seconds
- Detailed interactive event agenda
- Personal custom agenda for specific attendees
- Attendees can save specific sessions to their personal agenda
- Live stream conference sessions, networking and interaction
- Questions can be asked live from anywhere
- Easily cycle between sessions, video, comments and Q&A
- Includes a filterable, tiered directory of sponsors/exhibitors
- Dedicated profile for each company including information, downloads, products and video
- Interact with assigned representatives immediately
- Virtual industry sponsored satellite symposia
- Instant Messaging available between onsite and offsite participants
- Ability to filter between onsite and offsite participants
- Network and set up virtual face to face meetings with other users
- Participants can connect via video call to the members of your team
- Connect with onsite and offsite participants
- Offsite participants provided with a virtual meeting automatically
- In-App live video calling
- Auto notification when the virtual meeting begins
- Make notes and download post meeting
EIOC Leaderships
EIOC 2021 Testimonials
Photo Gallery
2021 CME Partner
2021 Supported By
2021 Main Sponsors
2021 Platinum Sponsors
2021 Gold Sponsors
2021 Healthcare Partner
2021 Silver Sponsors
2021 Support Sponsors
2021 Exhibitors
2021 Media Partners
OFFICIAL AIRLINE - FLY EMIRATES
The promo code is: EVE6EIO
Travel Validity : 16 – 28 October, 2022
A lot of exciting data for Lung Cancer at ASCO! These are the ones I will be definitely on the look out for. https://lnkd.in/dKDf7GBc
An excellent paper that’s showing how HER2-low-positive expression showed high instability from primary BC to residual disease after neoadjuvant treatment.
https://lnkd.in/dR5h-_rE https://lnkd.in/duMevS-Z
Finally first ASCO in person after the pandemic! I am looking forward to it! Abstracts titles just released and so much to look forward to. Here is my list of Breast Abstracts that I think will be of huge interest. https://lnkd.in/dhh3tjUZ
An interesting case control study that looks at the association of cumulative lifetime excess weight with risk of Colorectal Cancer. This large-scale population-based case-control study suggest that excess weight may have substantially higher ORs associat…https://lnkd.in/dRKPNHJb
Updated 3 year survival analysis of the phase II NADIM trial is out! patients with resectable stage IIIA NSCLC received pre op chemotherapy and nivolumab. OS at 36 months was 81.9%. TMB and PDL-1 was not was predictive of survival. low pretreatment levels…https://lnkd.in/dp6PuR_p